中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
9期
1196-1198
,共3页
张薛榜%李刚%邓霞%邹长林%谢聪颖%景钊%吴式琇
張薛榜%李剛%鄧霞%鄒長林%謝聰穎%景釗%吳式琇
장설방%리강%산하%추장림%사총영%경쇠%오식수
胃肿瘤%化学疗法,辅助%放射疗法,适形
胃腫瘤%化學療法,輔助%放射療法,適形
위종류%화학요법,보조%방사요법,괄형
Stomach neoplasms%Chemotherapy,adjuvant%Radiotherapy,conformal
目的 评价胃癌术后放疗同步紫杉醇顺铂方案治疗的临床疗效和毒性反应,比较适形放疗与常规放疗在放疗毒性反应方面的差异.方法 采用常规4野或三维适形放疗技术DT 60 Gy和紫杉醇135 mg/m2第1天,顺铂20 mg/m2第1~3天同步化疗,4周1次共2周期.结果 3年总生存率、3年无复发生存期分别为78.2%、70.9%,28.1%患者出现治疗失败.3级及以上毒性反应发生率为70.3%,主要毒性反应为消化道(28.1%)、血液学毒性(21.8%)和脱发(18.7%),1例患者发生治疗相关死亡.结论 胃癌术后的同步化疗方案效果较好,安全可行;适形放疗技术可以进一步减轻放疗相关毒性反应尤其是胃肠道反应.
目的 評價胃癌術後放療同步紫杉醇順鉑方案治療的臨床療效和毒性反應,比較適形放療與常規放療在放療毒性反應方麵的差異.方法 採用常規4野或三維適形放療技術DT 60 Gy和紫杉醇135 mg/m2第1天,順鉑20 mg/m2第1~3天同步化療,4週1次共2週期.結果 3年總生存率、3年無複髮生存期分彆為78.2%、70.9%,28.1%患者齣現治療失敗.3級及以上毒性反應髮生率為70.3%,主要毒性反應為消化道(28.1%)、血液學毒性(21.8%)和脫髮(18.7%),1例患者髮生治療相關死亡.結論 胃癌術後的同步化療方案效果較好,安全可行;適形放療技術可以進一步減輕放療相關毒性反應尤其是胃腸道反應.
목적 평개위암술후방료동보자삼순순박방안치료적림상료효화독성반응,비교괄형방료여상규방료재방료독성반응방면적차이.방법 채용상규4야혹삼유괄형방료기술DT 60 Gy화자삼순135 mg/m2제1천,순박20 mg/m2제1~3천동보화료,4주1차공2주기.결과 3년총생존솔、3년무복발생존기분별위78.2%、70.9%,28.1%환자출현치료실패.3급급이상독성반응발생솔위70.3%,주요독성반응위소화도(28.1%)、혈액학독성(21.8%)화탈발(18.7%),1례환자발생치료상관사망.결론 위암술후적동보화료방안효과교호,안전가행;괄형방료기술가이진일보감경방료상관독성반응우기시위장도반응.
Objective To evaluate the efficacy and toxicity of postoperative chemoradiation for D2 dissection gastric cancer,and to compare the difference of toxicity between confromal and traditional radiotherapy.Methods Sixty four patients with T3-4,N + or R1 were enrolled.Radioation was given to a total dose of 46Gy delivered in 23fractions by use of 3D-CRT or 4 fields traditional radiotherapy.Chemothrepy was administered with paclitaxel 135 mg/m2 day 1 and 29,cisplantin 20 mg/m2 day 1 ~3 and day 29 ~31 during radiotherapy.Results The median follow-up time was 40 months.The 3-year overall and relapse-free survival rates were 78.2% and 70.9%,respectively.Eighteen patients had tumor relapse.Fifty-three patients completed chemoradiotheray.Toxicities on grade 3 or above included gastrointestinal toxicity (28.1% ),eutropenia (21.8 % ) and alopecia ( 18.7% ).One patient died of hemorrhage of upper digestion tract.Conclusion Adjuvant radiotherapy with paclitaxol and cisplatin yielded satisfactory overall survival and disease-free survival in gastric cancer patients.The toxicity was manageable.Conformal radiotherapy seems to decrease the gastrointestinal toxicities compared to that occurred in the traditional radiotherapy.